Journal list menu
- Issue
British Journal of Pharmacology: Volume 153, Issue S1
Special Issue: Life Sciences
S1-S470March 2008
Export Citations
Introduction
Commentaries
Free Access
free
Gates and filters: unveiling the physiological roles of nicotinic acetylcholine receptors in dopaminergic transmission
- Pages: S2-S4
- First Published: 29 January 2009
Free Access
free
New drug targets in inflammation: efforts to expand the anti-inflammatory armoury
- Pages: S5-S6
- First Published: 29 January 2009
Reviews
Free Access
free
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go
- Pages: S7-S26
- First Published: 29 January 2009
Free Access
free
Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction
- Pages: S27-S34
- First Published: 29 January 2009
Free Access
free
Intracellular machinery for the transport of AMPA receptors
- Pages: S35-S43
- First Published: 29 January 2009
Free Access
free
Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery
- Pages: S44-S54
- First Published: 29 January 2009
Free Access
free
Ligand discovery and virtual screening using the program LIDAEUS
- Pages: S55-S67
- First Published: 29 January 2009
Free Access
free
Nicotinic acid: an old drug with a promising future
- Pages: S68-S75
- First Published: 29 January 2009
Free Access
free
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity
- Pages: S76-S81
- First Published: 29 January 2009
Free Access
free
Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions
- Pages: S82-S89
- First Published: 29 January 2009
Free Access
free
G-protein-coupled receptor heteromers: function and ligand pharmacology
- Pages: S90-S98
- First Published: 29 January 2009
Free Access
free
Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications
- Pages: S99-S111
- First Published: 29 January 2009
Free Access
free
Clinical pharmacological issues in the development of acute stroke therapies
- Pages: S112-S119
- First Published: 29 January 2009
Free Access
free
Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential
- Pages: S120-S124
- First Published: 29 January 2009
Free Access
free
Kinetics of G-protein-coupled receptor signals in intact cells
- Pages: S125-S132
- First Published: 29 January 2009
Free Access
free
The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders
- Pages: S133-S136
- First Published: 29 January 2009
Free Access
free
Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis
- Pages: S137-S153
- First Published: 29 January 2009
Free Access
free
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors
- Pages: S154-S166
- First Published: 29 January 2009
Free Access
free
G-protein-coupled receptor phosphorylation: where, when and by whom
- Pages: S167-S176
- First Published: 29 January 2009
Free Access
free
RIC-3: a nicotinic acetylcholine receptor chaperone
- Pages: S177-S183
- First Published: 29 January 2009
Free Access
free
The A2A-adenosine receptor: a GPCR with unique features?
- Pages: S184-S190
- First Published: 29 January 2009
Free Access
free
The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses
- Pages: S191-S199
- First Published: 29 January 2009
Free Access
free
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus
- Pages: S200-S215
- First Published: 29 January 2009
Free Access
free
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization
- Pages: S216-S229
- First Published: 29 January 2009
Free Access
free
Gastrointestinal roles for proteinase-activated receptors in health and disease
- Pages: S230-S240
- First Published: 29 January 2009
Free Access
free
Fibroblasts as novel therapeutic targets in chronic inflammation
- Pages: S241-S246
- First Published: 29 January 2009
Free Access
free
Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems
- Pages: S247-S262
- First Published: 29 January 2009
Free Access
free
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
- Pages: S263-S282
- First Published: 29 January 2009
Free Access
free
Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission
- Pages: S283-S297
- First Published: 29 January 2009
Free Access
free
β-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction
- Pages: S298-S309
- First Published: 29 January 2009
Free Access
free
Role of the brain-derived neurotrophic factor at glutamatergic synapses
- Pages: S310-S324
- First Published: 29 January 2009
Free Access
free
Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly
- Pages: S325-S338
- First Published: 29 January 2009
Free Access
free
Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria
- Pages: S347-S357
- First Published: 29 January 2009
Free Access
free
Conformational changes in G-protein-coupled receptors—the quest for functionally selective conformations is open
- Pages: S358-S366
- First Published: 29 January 2009
Free Access
free
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
- Pages: S367-S378
- First Published: 29 January 2009
Free Access
free
Agonist-selective mechanisms of GPCR desensitization
- Pages: S379-S388
- First Published: 29 January 2009
Free Access
free
Probing the role of AMPAR endocytosis and long-term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction
- Pages: S389-S395
- First Published: 29 January 2009
Free Access
free
Experimental models, neurovascular mechanisms and translational issues in stroke research
- Pages: S396-S405
- First Published: 29 January 2009
Free Access
free
Molecular epidemiology of clinically significant antibiotic resistance genes
- Pages: S406-S413
- First Published: 29 January 2009
Free Access
free
Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects
- Pages: S414-S427
- First Published: 29 January 2009
Free Access
free
The role of GSK-3 in synaptic plasticity
- Pages: S428-S437
- First Published: 29 January 2009
Free Access
free
The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology
- Pages: S438-S445
- First Published: 29 January 2009
Free Access
free
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells
- Pages: S457-S464
- First Published: 29 January 2009
Free Access
free
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment
- Pages: S465-S470
- First Published: 29 January 2009